vs
Inspire Medical Systems, Inc.（INSP）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
Inspire Medical Systems, Inc.的季度营收约是STURM RUGER & CO INC的1.8倍（$269.1M vs $151.1M），Inspire Medical Systems, Inc.同比增速更快（12.2% vs 3.6%），Inspire Medical Systems, Inc.自由现金流更多（$41.8M vs $12.3M），过去两年Inspire Medical Systems, Inc.的营收复合增速更高（28.1% vs 5.1%）
Inspire Medical Systems是一家专注于阻塞性睡眠呼吸暂停治疗的医疗科技企业，研发、生产并销售植入式神经刺激设备，面向无法耐受持续气道正压通气治疗的患者，核心市场覆盖北美、欧洲及部分亚太地区，服务睡眠医学、耳鼻喉科等临床领域。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
INSP vs RGR — 直观对比
营收规模更大
INSP
是对方的1.8倍
$151.1M
营收增速更快
INSP
高出8.6%
3.6%
自由现金流更多
INSP
多$29.5M
$12.3M
两年增速更快
INSP
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $269.1M | $151.1M |
| 净利润 | $136.1M | — |
| 毛利率 | 86.6% | 17.8% |
| 营业利润率 | 17.1% | 2.3% |
| 净利率 | 50.6% | — |
| 营收同比 | 12.2% | 3.6% |
| 净利润同比 | 286.4% | — |
| 每股收益（稀释后） | $4.57 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INSPRGR
| Q4 25 | $269.1M | $151.1M | ||
| Q3 25 | $224.5M | $126.8M | ||
| Q2 25 | $217.1M | $132.5M | ||
| Q1 25 | $201.3M | $135.7M | ||
| Q4 24 | $239.7M | $145.8M | ||
| Q3 24 | $203.2M | $122.3M | ||
| Q2 24 | $195.9M | $130.8M | ||
| Q1 24 | $164.0M | $136.8M |
净利润INSPRGR
| Q4 25 | $136.1M | — | ||
| Q3 25 | $9.9M | $1.6M | ||
| Q2 25 | $-3.6M | $-17.2M | ||
| Q1 25 | $3.0M | $7.8M | ||
| Q4 24 | $35.2M | — | ||
| Q3 24 | $18.5M | $4.7M | ||
| Q2 24 | $9.8M | $8.3M | ||
| Q1 24 | $-10.0M | $7.1M |
毛利率INSPRGR
| Q4 25 | 86.6% | 17.8% | ||
| Q3 25 | 85.8% | 15.1% | ||
| Q2 25 | 84.0% | 3.9% | ||
| Q1 25 | 84.7% | 22.0% | ||
| Q4 24 | 85.0% | 22.8% | ||
| Q3 24 | 84.1% | 18.5% | ||
| Q2 24 | 84.8% | 22.3% | ||
| Q1 24 | 84.9% | 21.5% |
营业利润率INSPRGR
| Q4 25 | 17.1% | 2.3% | ||
| Q3 25 | 4.3% | -2.7% | ||
| Q2 25 | -1.5% | -15.6% | ||
| Q1 25 | -0.7% | 6.2% | ||
| Q4 24 | 13.3% | 7.8% | ||
| Q3 24 | 7.0% | 3.1% | ||
| Q2 24 | 2.6% | 6.9% | ||
| Q1 24 | -9.3% | 5.5% |
净利率INSPRGR
| Q4 25 | 50.6% | — | ||
| Q3 25 | 4.4% | 1.2% | ||
| Q2 25 | -1.7% | -13.0% | ||
| Q1 25 | 1.5% | 5.7% | ||
| Q4 24 | 14.7% | — | ||
| Q3 24 | 9.1% | 3.9% | ||
| Q2 24 | 5.0% | 6.3% | ||
| Q1 24 | -6.1% | 5.2% |
每股收益（稀释后）INSPRGR
| Q4 25 | $4.57 | $0.22 | ||
| Q3 25 | $0.34 | $0.10 | ||
| Q2 25 | $-0.12 | $-1.05 | ||
| Q1 25 | $0.10 | $0.46 | ||
| Q4 24 | $1.17 | $0.62 | ||
| Q3 24 | $0.60 | $0.28 | ||
| Q2 24 | $0.32 | $0.47 | ||
| Q1 24 | $-0.34 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $308.3M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $781.2M | $283.8M |
| 总资产 | $907.3M | $342.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INSPRGR
| Q4 25 | $308.3M | $92.5M | ||
| Q3 25 | $322.6M | $80.8M | ||
| Q2 25 | $300.9M | $101.4M | ||
| Q1 25 | $369.2M | $108.3M | ||
| Q4 24 | $445.5M | $105.5M | ||
| Q3 24 | $411.0M | $96.0M | ||
| Q2 24 | $439.7M | $105.6M | ||
| Q1 24 | $441.4M | $115.3M |
股东权益INSPRGR
| Q4 25 | $781.2M | $283.8M | ||
| Q3 25 | $666.5M | $279.6M | ||
| Q2 25 | $677.8M | $289.3M | ||
| Q1 25 | $635.7M | $321.5M | ||
| Q4 24 | $689.7M | $319.6M | ||
| Q3 24 | $696.6M | $314.9M | ||
| Q2 24 | $638.1M | $321.5M | ||
| Q1 24 | $589.0M | $332.0M |
总资产INSPRGR
| Q4 25 | $907.3M | $342.0M | ||
| Q3 25 | $807.7M | $342.3M | ||
| Q2 25 | $802.2M | $349.5M | ||
| Q1 25 | $730.8M | $379.0M | ||
| Q4 24 | $808.4M | $384.0M | ||
| Q3 24 | $796.2M | $373.5M | ||
| Q2 24 | $728.4M | $376.7M | ||
| Q1 24 | $685.8M | $385.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $52.5M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $41.8M | $12.3M |
| 自由现金流率自由现金流/营收 | 15.5% | 8.2% |
| 资本支出强度资本支出/营收 | 4.0% | 2.1% |
| 现金转化率经营现金流/净利润 | 0.39× | — |
| 过去12个月自由现金流最近4个季度 | $78.5M | $38.5M |
8季度趋势，按日历期对齐
经营现金流INSPRGR
| Q4 25 | $52.5M | $15.5M | ||
| Q3 25 | $68.5M | $12.9M | ||
| Q2 25 | $2.7M | $14.7M | ||
| Q1 25 | $-6.7M | $11.1M | ||
| Q4 24 | $69.2M | $20.0M | ||
| Q3 24 | $52.3M | $9.4M | ||
| Q2 24 | $-78.0K | $18.7M | ||
| Q1 24 | $8.9M | $7.3M |
自由现金流INSPRGR
| Q4 25 | $41.8M | $12.3M | ||
| Q3 25 | $58.1M | $7.0M | ||
| Q2 25 | $-6.3M | $9.1M | ||
| Q1 25 | $-15.1M | $10.0M | ||
| Q4 24 | $62.2M | $16.4M | ||
| Q3 24 | $44.3M | $2.6M | ||
| Q2 24 | $-12.5M | $10.1M | ||
| Q1 24 | $-2.8M | $5.6M |
自由现金流率INSPRGR
| Q4 25 | 15.5% | 8.2% | ||
| Q3 25 | 25.9% | 5.5% | ||
| Q2 25 | -2.9% | 6.9% | ||
| Q1 25 | -7.5% | 7.4% | ||
| Q4 24 | 25.9% | 11.2% | ||
| Q3 24 | 21.8% | 2.1% | ||
| Q2 24 | -6.4% | 7.7% | ||
| Q1 24 | -1.7% | 4.1% |
资本支出强度INSPRGR
| Q4 25 | 4.0% | 2.1% | ||
| Q3 25 | 4.6% | 4.6% | ||
| Q2 25 | 4.1% | 4.2% | ||
| Q1 25 | 4.2% | 0.8% | ||
| Q4 24 | 2.9% | 2.5% | ||
| Q3 24 | 3.9% | 5.5% | ||
| Q2 24 | 6.3% | 6.6% | ||
| Q1 24 | 7.1% | 1.3% |
现金转化率INSPRGR
| Q4 25 | 0.39× | — | ||
| Q3 25 | 6.90× | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | -2.24× | 1.43× | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 2.83× | 1.98× | ||
| Q2 24 | -0.01× | 2.27× | ||
| Q1 24 | — | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INSP
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
